Načítá se...
Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia
BACKGROUND: Opportunistic fungal infections are a major cause of morbidity and mortality in neutropenic cancer patients and antifungal therapy is used both empirically and therapeutically in these patients. OBJECTIVES: To compare the benefits and harms of voriconazole with those of amphotericin B an...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2014
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6457750/ https://ncbi.nlm.nih.gov/pubmed/24563222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD004707.pub3 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|